Sinopharm Tech Holdings (HKSE:08156) EV-to-Revenue : 0.47 (As of May. 27, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sinopharm Tech Holdings's enterprise value is HK$21.70 Mil. Sinopharm Tech Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$46.66 Mil. Therefore, Sinopharm Tech Holdings's EV-to-Revenue for today is 0.47.

The historical rank and industry rank for Sinopharm Tech Holdings's EV-to-Revenue or its related term are showing as below:

HKSE:08156' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.28 Med: 25.49 Max: 124.26
Current: 0.47

During the past 13 years, the highest EV-to-Revenue of Sinopharm Tech Holdings was 124.26. The lowest was 0.28. And the median was 25.49.

HKSE:08156's EV-to-Revenue is ranked better than
87.63% of 2789 companies
in the Software industry
Industry Median: 2.14 vs HKSE:08156: 0.47

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Sinopharm Tech Holdings's stock price is HK$0.11. Sinopharm Tech Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.26. Therefore, Sinopharm Tech Holdings's PS Ratio for today is 0.43.

Sinopharm Tech Holdings EV-to-Revenue Historical Data

The historical data trend for Sinopharm Tech Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings EV-to-Revenue Chart

Sinopharm Tech Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-Revenue

Get a 7-Day Free Trial

25.98

5.63

16.55

14.17

1.30

Sinopharm Tech Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															4.31	4.23	1.30	0.61	0.42

Competitive Comparison of Sinopharm Tech Holdings's EV-to-Revenue

For the Software - Application subindustry, Sinopharm Tech Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Tech Holdings's EV-to-Revenue Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's EV-to-Revenue falls into.

Sinopharm Tech Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sinopharm Tech Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	21.701	/	46.658
	=	0.47

Sinopharm Tech Holdings's current Enterprise Value is HK$21.70 Mil.
Sinopharm Tech Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$46.66 Mil.

Sinopharm Tech Holdings (HKSE:08156) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sinopharm Tech Holdings's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.11	/	0.255
	=	0.43

Sinopharm Tech Holdings's share price for today is HK$0.11.
Sinopharm Tech Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.26.

Sinopharm Tech Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Tech Holdings (HKSE:08156) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG

Website

https://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.

Executives

Best Frontier Investments Limited
Chan Kin Ho Philip	2201 Interest of corporation controlled by you
Lam Yui Keung	2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited	2101 Beneficial owner
Main Key Investments Limited	2201 Interest of corporation controlled by you
Guo Lei	2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited	2101 Beneficial owner
Yam Tak Cheung	2201 Interest of corporation controlled by you
Chan Tung Mei	2202 Interest of your spouse
Cheung Kwai Lan	2201 Interest of corporation controlled by you
Tse Siu Hoi	2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.)	2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines